We're proud to partner with advisors from organizations that share our mission to support quality-driven NASH care delivery.
baylor college of medicine
Norman Sussman, MD
Dr. Norman L. Sussman is an active member of Baylor St. Luke’s Liver Center. He is Board Certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. His clinical interests cover all aspects of liver disease, and his research interests include assessment and management of acute liver failure, artificial liver support, new agents to treat viral hepatitis, and complications of advanced cirrhosis.
Fasiha Kanwal, MD, MSHS
Dr. Fasiha Kanwal is a gastroenterologist at Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, and associate professor of medicine in the department of medicine at Baylor College of Medicine, both in Houston, Texas.
Douglas Dieterich, MD
Dr. Douglas Dieterich is currently Professor of Medicine in the Division of Liver Diseases and also Director of Continuing Medical Education in the Department of Medicine at Mount Sinai School of Medicine, New York, NY. He has a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases.
Dr. Dieterich is an investigator for many ongoing clinical trials evaluating the safety and efficacy of new antiviral treatments for chronic hepatitis B, C, and NASH.
Amon Asgharpour, MD
Dr. Amon Asgharpour is an Assistant Professor in the Department of Medicine, Division of Liver Diseases. He is board certified in Internal Medicine and Gastroenterology.
He is the author of a multitude of publications and his research at Mount Sinai will focus on clinical trials and translational research in nonalcoholic fatty liver disease and steatohepatitis.
Mary Rinella, MD
Dr. Mary Rinella is a Professor of Medicine at Northwestern University’s Feinberg School of Medicine. She studied basic mechanisms of steatohepatitis with the support of the American Gastroenterological Association and the National Institutes of Health for ten years.
Currently, her focus is on clinical research in the area of nonalcoholic fatty liver disease/NASH both before and after liver transplantation. Her primary clinical focus within the NASH realm is on the associations between NASH and cardiovascular disease and the occurrence of NASH after liver transplantation. She is the Director of the Northwestern Fatty Liver Program and currently serves as Chair of the NAFLD/NASH Special Interest Group at the American Association for the Study of Liver Diseases.
OCHSNER health system
George Therapondos, MD
Dr. George Therapondos is currently the Hepatology Section Head at the Ochsner MultiOrgan Transplant Institute.
He was director of the Clinical Trials Unit of the Multi-organ Transplant Program of the University Health Network in Toronto, Canada and worked as Assistant Professor and Staff Hepatologist at Toronto General Hospital.
His most research interests have focused on adult deceased and living donor liver transplantation and quality of life issues in liver patients.
Nigel Girgrah, MD, PhD
Dr. Nigel Girgrah received both his MD and PhD at the University of Toronto. He has specialist certification in both gastroenterology and internal medicine with the Royal College of Physicians and Surgeons of Canada.
He served as Director of Education for the Multi-Organ Transplant Program at the University Health Network in Toronto for several years.
He completed further research training in Hepatology in the area of portal hypertension and his clinical expertise is in end-stage liver disease and transplant hepatology. Additional clinical and research areas of interest include recurrent viral disease post-liver transplantation and living donation liver transplantation.